The Scientist

» cancer and disease/medicine

Most Recent

image: DNA Truth or Dare

DNA Truth or Dare

By | July 1, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

1 Comment

image: Medical Mavericks

Medical Mavericks

By | July 1, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

11 Comments

image: Meeting of the Minds

Meeting of the Minds

By | July 1, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

1 Comment

image: Dynamic Delivery

Dynamic Delivery

By | July 1, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

0 Comments

image: Polypharmacy

Polypharmacy

By | July 1, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

14 Comments

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

1 Comment

image: Jumping Genes a Cause of Cancer?

Jumping Genes a Cause of Cancer?

By | June 28, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

2 Comments

image: Link to Second Heart Attack Uncovered

Link to Second Heart Attack Uncovered

By | June 27, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

1 Comment

image: iPad Affects Shunt Settings

iPad Affects Shunt Settings

By | June 26, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

0 Comments

image: Natural Antidepressant Discovered

Natural Antidepressant Discovered

By | June 25, 2012

Learning the intricacies of your own genetic profile is a double-edged sword.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech